Tsujimoto M - Search Results

1

Olaparib Potentiates Anticancer Drug Cytotoxicity via 53BP1 in Oesophageal Squamous Cell Carcinoma Cells.

Miyamoto K, Minegaki T, Hirano S, Hayashi I, Tsujimoto M, Nishiguchi K. Miyamoto K, et al. Among authors: tsujimoto m. Anticancer Res. 2020 Feb;40(2):813-823. doi: 10.21873/anticanres.14013. Anticancer Res. 2020. PMID: 32014924

2

Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines.

Kitada N, Takara K, Minegaki T, Itoh C, Tsujimoto M, Sakaeda T, Yokoyama T. Kitada N, et al. Among authors: tsujimoto m. Cancer Chemother Pharmacol. 2008 Sep;62(4):577-84. doi: 10.1007/s00280-007-0640-3. Epub 2007 Nov 21. Cancer Chemother Pharmacol. 2008. PMID: 18030470

3

Comparative analysis of cell injury after exposure to antitumor platinum derivatives in kidney tubular epithelial cells.

Kitada N, Takara K, Itoh C, Minegaki T, Tsujimoto M, Sakaeda T, Yokoyama T. Kitada N, et al. Among authors: tsujimoto m. Chemotherapy. 2008;54(3):217-23. doi: 10.1159/000140465. Epub 2008 Jun 18. Chemotherapy. 2008. PMID: 18560229

4

The structure-activity correlation on the inhibitory effects of flavonoids on cytochrome P450 3A activity.

Tsujimoto M, Horie M, Honda H, Takara K, Nishiguchi K. Tsujimoto M, et al. Biol Pharm Bull. 2009 Apr;32(4):671-6. doi: 10.1248/bpb.32.671. Biol Pharm Bull. 2009. PMID: 19336903 Free article.

5

Inhibitory effects of uraemic toxins 3-indoxyl sulfate and p-cresol on losartan metabolism in vitro.

Tsujimoto M, Higuchi K, Shima D, Yokota H, Furukubo T, Izumi S, Yamakawa T, Otagiri M, Hirata S, Takara K, Nishiguchi K. Tsujimoto M, et al. J Pharm Pharmacol. 2010 Jan;62(1):133-8. doi: 10.1211/jpp.62.01.0015. J Pharm Pharmacol. 2010. PMID: 20723009

6

Influence of serum in hemodialysis patients on the expression of intestinal and hepatic transporters for the excretion of pravastatin.

Tsujimoto M, Hatozaki D, Shima D, Yokota H, Furukubo T, Izumi S, Yamakawa T, Minegaki T, Nishiguchi K. Tsujimoto M, et al. Ther Apher Dial. 2012 Dec;16(6):580-7. doi: 10.1111/j.1744-9987.2012.01100.x. Epub 2012 Aug 29. Ther Apher Dial. 2012. PMID: 23190519

7

Factors affecting the sensitivity of human-derived esophageal carcinoma cell lines to 5-fluorouracil and cisplatin.

Minegaki T, Takara K, Hamaguchi R, Tsujimoto M, Nishiguchi K. Minegaki T, et al. Among authors: tsujimoto m. Oncol Lett. 2013 Feb;5(2):427-434. doi: 10.3892/ol.2012.1014. Epub 2012 Nov 5. Oncol Lett. 2013. PMID: 23420099 Free PMC article.

8

Effects of decreased vitamin D and accumulated uremic toxin on human CYP3A4 activity in patients with end-stage renal disease.

Tsujimoto M, Nagano Y, Hosoda S, Shiraishi A, Miyoshi A, Hiraoka S, Furukubo T, Izumi S, Yamakawa T, Minegaki T, Nishiguchi K. Tsujimoto M, et al. Toxins (Basel). 2013 Aug 19;5(8):1475-85. doi: 10.3390/toxins5081475. Toxins (Basel). 2013. PMID: 23965431 Free PMC article.

9

Possibility of decrease in CYP1A2 function in patients with end-stage renal disease.

Tsujimoto M, Sugimoto S, Nagatomo M, Furukubo T, Izumi S, Yamakawa T, Minegaki T, Nishiguchi K. Tsujimoto M, et al. Ther Apher Dial. 2014 Apr;18(2):174-80. doi: 10.1111/1744-9987.12100. Epub 2013 Sep 30. Ther Apher Dial. 2014. PMID: 24119207

10

Uremic toxins enhance statin-induced cytotoxicity in differentiated human rhabdomyosarcoma cells.

Uchiyama H, Tsujimoto M, Shinmoto T, Ogino H, Oda T, Yoshida T, Furukubo T, Izumi S, Yamakawa T, Tachiki H, Minegaki T, Nishiguchi K. Uchiyama H, et al. Among authors: tsujimoto m. Toxins (Basel). 2014 Sep 3;6(9):2612-25. doi: 10.3390/toxins6092612. Toxins (Basel). 2014. PMID: 25192420 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

833 results

Search Page

Filters